Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate
Clinical trial NCT00369304 · COMPLETED
Trial details
- NCT number
- NCT00369304
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2006-08-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.